Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking
- PMID: 15135219
- DOI: 10.1016/j.molbrainres.2004.02.021
Loss of glial fibrillary acidic protein results in decreased glutamate transport and inhibition of PKA-induced EAAT2 cell surface trafficking
Abstract
Loss of the astrocyte-specific intermediate filament protein, glial fibrillary acidic protein (GFAP) results in an increased susceptibility to ischemic insult, enhanced hippocampal LTP, and decreased cerebellar long-term depression (LTD). Because glutamate receptor activation plays a key role in cell death and cellular plasticity responses, we wanted to determine if alterations in glial glutamate transport could contribute to the GFAP null phenotype. To address functional changes in glutamate transport, we measured glutamate uptake in cortical, cerebellar, and hippocampal synaptosomal preparations from age-matched adult wild type and GFAP null mice and demonstrated a 25-30% reduction in the V(max) for d-aspartate uptake in the cortex and hippocampus of GFAP null animals. Western blot analysis of cortical synaptosomal fractions from wild type and GFAP null animals demonstrated that loss of GFAP results in decreases in both astrocytic (EAAT1) and neuronal (EAAT3) glutamate transporter subtypes. Immunohistochemical analysis demonstrated a region-specific modification of neuronal glutamate transporter, EAAT3 trafficking in the GFAP null phenotype. Analysis of primary cortical astrocyte cultures prepared from GFAP null and wild type mice demonstrated that loss of GFAP results in an inability to traffic the glial glutamate transporter, EAAT2, to the surface of the cell following protein kinase A (PKA) stimulation by dibutyryl cAMP. Taken together, these results suggest that the intermediate filament protein, GFAP plays a key role in modulating astrocytic and neuronal glutamate transporter trafficking and function.
Similar articles
-
Neuronal glutamate transporter EAAT4 is expressed in astrocytes.Glia. 2003 Oct;44(1):13-25. doi: 10.1002/glia.10268. Glia. 2003. PMID: 12951653
-
Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuron-enriched cultures.Neurochem Int. 2005 Mar;46(4):337-46. doi: 10.1016/j.neuint.2004.10.006. Epub 2005 Jan 13. Neurochem Int. 2005. PMID: 15707698
-
Glutamate transporter expression and function in human glial progenitors.Glia. 2004 Jan 15;45(2):133-43. doi: 10.1002/glia.10310. Glia. 2004. PMID: 14730707
-
Control of the phosphorylation of the astrocyte marker glial fibrillary acidic protein (GFAP) in the immature rat hippocampus by glutamate and calcium ions: possible key factor in astrocytic plasticity.Braz J Med Biol Res. 1997 Mar;30(3):325-38. doi: 10.1590/s0100-879x1997000300005. Braz J Med Biol Res. 1997. PMID: 9246230 Review.
-
Protein kinase C-dependent remodeling of glutamate transporter function.Mol Interv. 2004 Feb;4(1):48-58. doi: 10.1124/mi.4.1.48. Mol Interv. 2004. PMID: 14993476 Review.
Cited by
-
Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.Curr Drug Targets. 2013 Oct;14(11):1225-36. doi: 10.2174/13894501113149990156. Curr Drug Targets. 2013. PMID: 23469922 Free PMC article. Review.
-
Glutamate transporter cluster formation in astrocytic processes regulates glutamate uptake activity.J Neurosci. 2004 Jul 14;24(28):6301-6. doi: 10.1523/JNEUROSCI.1404-04.2004. J Neurosci. 2004. PMID: 15254085 Free PMC article.
-
A novel serum free primary astrocyte culture method that mimic quiescent astrocyte phenotype.J Neurosci Methods. 2019 May 15;320:50-63. doi: 10.1016/j.jneumeth.2019.03.013. Epub 2019 Mar 20. J Neurosci Methods. 2019. PMID: 30904500 Free PMC article.
-
Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stress.J Huazhong Univ Sci Technolog Med Sci. 2014 Dec;34(6):838-844. doi: 10.1007/s11596-014-1362-5. Epub 2014 Dec 6. J Huazhong Univ Sci Technolog Med Sci. 2014. PMID: 25480579
-
Reactive astrocytes as treatment targets in Alzheimer's disease-Systematic review of studies using the APPswePS1dE9 mouse model.Glia. 2021 Aug;69(8):1852-1881. doi: 10.1002/glia.23981. Epub 2021 Feb 25. Glia. 2021. PMID: 33634529 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous